|
Medical Breakthrough for Chronic Kidney Disease Sufferers
SBWire (press release) Los Angeles, CA — (SBWIRE) — 09/26/2013 — Dr. Robert Galarowicz, N.D. is a nephrologist (kidney specialist), and as such he’s treated countless patients for various forms of kidney disease. This includes patients on dialysis, as well as those … Northwest Kidney Centers to move, expand its Kirkland dialysis clinic next springKirkland Reporter |
Some childhood cancer survivors may face kidney problems – NephrologyNews.com
Health and Beauty NewsSome childhood cancer survivors may face kidney problemsNephrologyNews.comThe researchers found that compared with childhood cancer survivors who did not receive kidney-damaging treatments, those who were treated with ifosfamide o…
Newly identified antibodies effectively treat Alzheimer's-like disease in mice – Science Codex
Medical Daily |
Newly identified antibodies effectively treat Alzheimer’s-like disease in mice
Science Codex Alzheimer’s disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can … Antibodies Could Halt Alzheimer’s And Dementia Onset, Improve Cognitive …Medical Daily |
Novel Drug Prevents Common Viral Disease in Stem-Cell Transplant Patients – Science Daily (press release)
|
Novel Drug Prevents Common Viral Disease in Stem-Cell Transplant Patients
Science Daily (press release) Sep. 25, 2013 — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s … Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir …MarketWatch Cytomegalovirus—a ‘stealth’ pathogen—gains attention in the drug development …Nature Medicine blog (blog) CMX001 reduced cytomegalovirus disease after HSCTHealio |
Hanging In The Mist: Mercury Contamination In South India – Center for Research on Globalization
Center for Research on GlobalizationHanging In The Mist: Mercury Contamination In South IndiaCenter for Research on GlobalizationWith all the lush greenery, the abundance of fruits being grown and the chocolate box cottages dotting the slopes and aroun…
Liver transplant center to be set up in Guatemala – Taipei Times
Liver transplant center to be set up in GuatemalaTaipei TimesTo prepare for the establishment of the liver transplant center, 13 Guatemalan physicians completed a year-long internship program for clinical practice in liver transplantation that started …
Withhold Gliptins From Diabetics With Heart Failure? – Medscape
Medscape |
Withhold Gliptins From Diabetics With Heart Failure?
Medscape BARCELONA, Spain — New data from EXAMINE, the cardiovascular-safety trial with the type 2 diabetes drug alogliptin (Nesina, Takeda Pharmaceuticals), has shown no significantly increased risk for heart failure (HF) with use of this dipeptidyl peptidase … |
Drug companies seek to deliver patents message to Indian prime minister – Politico
Politico |
Drug companies seek to deliver patents message to Indian prime minister
Politico Drug manufacturers say India’s most egregious act came in March 2012, when its controller general of patents, designs and trademarks granted a compulsory license for local generics company Natco to sell a copy of Bayer’s Nexavar, which treats liver and … |
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 … – Fort Mills Times
|
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 …
Fort Mills Times The latest report ‘Global Monoclonal Antibodies Pipeline Capsule – 2013′ provides up-to-date information on key Research and Development activities (R&D) in the global monoclonal antibodies market. It covers active monoclonal antibodies pipeline … |
Boxed warning for HBV risk added to Rituxan, Arzerra – Clinical Advisor
Medscape |
Boxed warning for HBV risk added to Rituxan, Arzerra
Clinical Advisor The FDA has announced that the anti-CD20-directed monoclonal antibodies rituximab (Rituxan) and ofatumumab (Arzerra) will carry a boxed warning for immunosupression-related reactivation of hepatitis B virus (HBV) in a drug safety communication. Boxed Warning on HBV Reactivation for Blood Cancer DrugsMedscape FDA updates ‘box warning’ for Arzerra and Rituxan to include Hepatitis B …The Global Dispatch Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labelingHealio Pharmaceutical Processing all 5 news articles » |